Steward Partners Investment Advisory, LLC Alnylam Pharmaceuticals, Inc. Transaction History
Steward Partners Investment Advisory, LLC
- $9.37 Billion
- Q2 2024
A detailed history of Steward Partners Investment Advisory, LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 890 shares of ALNY stock, worth $243,103. This represents 0.0% of its overall portfolio holdings.
Number of Shares
890
Previous 715
24.48%
Holding current value
$243,103
Previous $106,000
103.77%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding ALNY
# of Institutions
614Shares Held
108MCall Options Held
2.33MPut Options Held
2.17M-
Capital World Investors Los Angeles, CA15MShares$4.09 Billion0.61% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.5MShares$3.42 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.61 Billion0.05% of portfolio
-
Wellington Management Group LLP Boston, MA6.21MShares$1.7 Billion0.28% of portfolio
-
Baillie Gifford & CO6.03MShares$1.65 Billion1.16% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $33.6B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...